Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy.
Oehus AK, Kroeze SGC, Schmidt-Hegemann NS, Vogel MME, Kirste S, Becker J, Burger IA, Derlin T, Bartenstein P, Eiber M, Mix M, la Fougère C, Belka C, Combs SE, Grosu AL, Müller AC, Guckenberger M, Christiansen H, Henkenberens C.
Oehus AK, et al. Among authors: kroeze sgc.
BMC Cancer. 2020 Apr 29;20(1):362. doi: 10.1186/s12885-020-06883-5.
BMC Cancer. 2020.
PMID: 32349700
Free PMC article.